1. Calculation of potential inflation-indexed rebates for Medicare Part B drugs Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017 Subject(s): Drug CostsInsurance, Pharmaceutical Services -- economicsMedicare Part B -- economicsCost ControlCost SavingsMedicaid -- economicsHumansUnited StatesUnited States. Department of Health and Human Services.
